Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73... (ities of our Research business in analyt...)

HOME >> MEDICINE >> TECHNOLOGY

Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81.

Date:10/25/2011

ities of our Research business in analytical chemistry, biology, traditional chemistry and materials science will enable us to achieve low to mid single digit organic sales growth in our Research business in the 4th quarter.

Continued emphasis on growth opportunities in fine chemicals; in our international markets; and via e-commerce channels.

At current exchange rates, currency is expected to increase reported sales growth by about 4% over the prior year.

The recent acquisitions of Vetec, Resource Technology Corporation and Cerilliant Corporation are expected to contribute 1-2% to reported sales growth.

Our outlook for the fourth quarter for diluted adjusted earnings per share is a range of $0.85 to $0.93. Our reported diluted EPS, excluding restructuring costs, for the nine months ended September 30, 2011 is $2.88, implying a full year outlook to be in a range from $3.73 to $3.81.

Changes in foreign currency exchange rates are expected to lower Q4 diluted EPS by $0.02 -$0.03 compared to our previous outlook. A higher effective tax rate of 30% to 31% in Q4 will reduce otherwise reportable diluted EPS by $0.02 to $0.03 in Q4 compared to our previous outlook. Both of these factors have been considered in our guidance for Q4.

The effective tax rate for full year 2011 is now expected to be 28% to 29%, reduced from 29% to 30% in our previous outlook.

Recent acquisitions are expected to be neutral to mildly accretive to our diluted earnings per share in 2011.

This EPS outlook excludes the impact of restructuring and other special charges.

Management expects free cash flow for 2011 to be about $400 million.

Net cash provided by operating activities is expected to exceed $520 million.

Capital expenditures are expected to be approximately $120 million.

Initiatives to optimize working capital to support anticipated growth and customer service are expected to co

SOURCE Sigma-Aldrich
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
3. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
4. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
5. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
6. Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
7. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
8. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
9. Sigma-Aldrich to Present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010
10. Sigma-Aldrich(R) Licenses RAFT Polymerization Technology From CSIRO(R)
11. Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc.

Post Your Comments:

(Date:5/24/2013)... BEIJING , May 24, 2013 China ... "Company"), a leading fully integrated plasma-based biopharmaceutical company in ... Company has recently learned from a public announcement issued ... a public company listed on Shenzhen Stock Exchange, that ... Chan ("Ms. Chan"), one of the shareholders ...

(Date:5/24/2013)... , May 24, 2013 In accordance with Rule ... Rule 14e-1 of the United States Exchange Act, Echo Pharma ... offer for Elan Corporation (NYSE: ELN). Background ... Pharma") made an offer for the entire of the issued ... ("Elan") (the "Original Offer"). On 20 May ...

(Date:5/24/2013)... The potential of the pulmonary route as ... has been receiving undeniable attention with the recent advances ... crucial formulation considerations for orally inhaled products together with ... in the efficiency of pulmonary delivery, and great strides ... techniques and devices in recent years. With ...

[0] China Biologic Comments on the Proposed Shanghai RAAS Transaction [0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements [0] Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany

... 2011 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) ... quarter and full year 2010 on Wednesday, January 26, 2011 ... president and chief executive officer, will lead the call. On ... the fourth quarter and year ended December 31, 2010. ...

... Applied Precision is pleased to announce that ... Dougherty, senior scientist, have been chosen to present ... BiOS SPIE Photonics West. Three-dimensional ... that doubles the lateral and axial resolution, providing ...

Cached Medicine Technology:Amylin Pharmaceuticals to Webcast Year-End Financial Results 2 Applied Precision Scientific Team to Present 3D-SIM Paper at BiOS in San Francisco 2

Amylin Pharmaceuticals to Webcast Year-End Financial Results Applied Precision Scientific Team to Present 3D-SIM Paper at BiOS in San Francisco

(Date:5/25/2013)... May 25, 2013 This week idcloak Technologies ... to Facebook in countries where the site is blocked. ... user faces none of the site compatibility problems associated with ... Technologies, explains how a user may apply IP Port proxies ... the benefits of doing so are. , “When a user ...

(Date:5/25/2013)... NYC,NY (PRWEB) May 25, 2013 Dr. ... only non-invasive procedure FDA-approved to lift skin on the neck, ... available at her practice, Medical Aesthetics. , Ultherapy is a ... body’s own natural healing process to lift the skin over ... the first time, to see and then treat the deepest ...

(Date:5/25/2013)... 25, 2013 Actos lawsuit ... U.S. District Court, Western District of Louisiana, continue to ... a Case Management Order issued on May 21st, the ... contested motions in the Actos bladder cancer litigation, as ... Actos Product Liability Litigation, MDL No. 2299) , “We ...

(Date:5/25/2013)... TX (PRWEB) May 25, 2013 Studies ... those who are carrying excessive weight and their inability ... for many, simply losing weight can naturally relieve many ... found that improvement in sleep quality was significantly associated ... six month study dated November 6th, 2012, ...

(Date:5/25/2013)... 2013 The latest report from ... bowel syndrome (IBS) to bloating, constipation, diarrhea and ... long-lasting, embarrassing, frustrating and difficult health issues to ... health have provided a cure for these ... contributing to digestive health issues, a healthy diet ...

Breaking Medicine News(10 mins):Health News:idcloak Launches Proxy Web Browser for Blocked Facebook Users 2 Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2 Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2 Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2 Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2

[0] idcloak Launches Proxy Web Browser for Blocked Facebook Users [0] Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ [0] Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep [0] Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org

... hearing loss in laboratory animals, according to two new ... of a pill that could stave off noise-induced and ... findings will be reported Wednesday at the Association for ... author Colleen Le Prell, Ph.D., a researcher at the ...

... National Head Start Association (NHSA) issued the following statement ... is the director of the Albina Head Start program ... be created -- and more than 200,000 existing jobs ... has signed into law the economic recovery package containing ...

... Quarterly EPS of $0.39, Total Revenues of $109.1 Million ... Total Revenues by 17% -- Company Generates $178.3 Million ... Gen-Probe Incorporated (Nasdaq: GPRO ... quarter and full year ended December 31, 2008, including ...

... MADISON, Wis., Feb. 17 /PRNewswire-FirstCall/ -- Cogdell ... appointment of Roger Herritz as President of the Midwest ... Inpatient Project Delivery for the Company,s wholly owned subsidiary, ... the Company,s Madison office, Mr. Herritz will be responsible ...

... Lingering physical effects of cancer a likely cause, finds study, ... fighting cancer wasn,t hard enough, a new Dutch study concludes ... be able to find a job. , The meta-analysis of ... those who,d battled cancer were out of work vs. 15.2 ...

... sent today to,President Obama and members of the ... leadership of Congress on the enactment of,the American ... the first time,provides financial incentives to physicians who ... improve both the quality and cost-,effectiveness of patient ...

Vitamin supplements may protect against noise-induced hearing loss NHSA: President Obama, Congress Deserve High Praise for $2.1 Billion in Recovery Package for Head Start Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 Cogdell Spencer Names Herritz and Wolters to Key Leadership Positions Within Erdman One in Three Cancer Survivors on Unemployment Line Allscripts Applauds Economic Stimulus Incentives Rewarding Physicians for Using Electronic Health Records

The MACS VA_500 (variable atmosphere) is primarily for the study and isolation of microaerophilic organisms,including Campylobacter spp,Helicobacter pylori and other similarly fastdious organisms....

... an electrical power supply, MERKUR offers a broad ... a gas spring for ease of operation. For ... a foot pedal hydraulic system. Thanks to its ... anytime in a highly mobile and flexible manner. ...

... table MARS Enduro is the ideal ... are required before, during or directly ... motorised longitudinal adjustment and the filigreed ... conditions in examination, induction and operating ...

... Top Rotation provides uncommon bi-directional flexibility, ... Hercules 6700B eliminates any conflicts between ... while providing ample leg room for ... procedures. Removable back and leg sections ...

Medicine Products:

VA-500 Merkur Mars Enduro Hercules 6700B